Chinese venture capital investment in US biotech falls as Washington tightens scrutiny of funding from overseas, German chemicals group BASF cuts its full-year forecast and warns that second-quarter profits would almost halve and Deutsche Bank begins the culling of 18,000 jobs, with whole teams of equity traders being dismissed. Plus, the FT’s US legal and enforcement correspondent, Kadhim Shubber, explains the sex trafficking charges against money manager Jeffrey Epstein. 



For information regarding your data privacy, visit acast.com/privacy

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast